Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > 1.6 Million Shares Traded In The Last 45 Minutes Of Trading!

<< Previous

Bullboard Posts

Next >>

Post by blinkieon Feb 02, 2021 4:25pm

273 Views

Post# 32450142

1.6 Million Shares Traded In The Last 45 Minutes Of Trading!

I has a look attICO around 3:15 (truthfully to see if anyone responded to my post) & ICO had moved up to $0.07. Volume was approximately 657,000.

Then in the last 45 minutes roughly 1.6 Million shares were added to the trading and the price went up to $0.08!!!

Both nice and interesting.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market